Creating a blood test to detect neurodegenerative diseases like Alzheimer's
Development of a blood-based test for neurodegenerative diseases
This study is working on a new blood test that can help doctors spot Alzheimer's and other brain diseases earlier by looking for specific proteins that are out of shape, making it easier to get the right treatment for you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | 3d Bioanalytix, INC. NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project ID | NIH-10922630 on NIH RePORTER |
What this research studies
This research aims to develop a blood-based diagnostic test that can identify and differentiate neurodegenerative diseases, particularly Alzheimer's disease. By utilizing a novel technology called Covalent Protein Painting, the researchers will analyze misfolded protein aggregates that are characteristic of these conditions. This approach seeks to provide an early detection method, which is currently lacking, and could help physicians make more accurate diagnoses and tailor treatments accordingly.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing early signs of cognitive decline or those at risk for neurodegenerative diseases.
Not a fit: Patients who are not experiencing cognitive issues or who have already been diagnosed with advanced neurodegenerative diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a reliable blood test that allows for earlier and more accurate diagnosis of neurodegenerative diseases.
How similar studies have performed: While the approach of using blood tests for neurodegenerative disease detection is gaining interest, this specific method using Covalent Protein Painting is relatively novel and has not been widely tested.
Where this research is happening
San Diego, United States
- 3d Bioanalytix, INC. — San Diego, United States (Active)
Researchers
- Principal investigator: Pankow, Sandra — 3d Bioanalytix, INC.
- Study coordinator: Pankow, Sandra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.